Right. It's interesting, because my colleague Mr. Johns referenced it. Clearly, he presented a biased option, which, sadly, misuses the study and doesn't talk about the opioid agonist therapy, which exists inside the study but is not talked about inside the study.
We're firm believers on this side of the House that opioid agonist therapy and rehabilitation are the way to go. What we're having trouble with and what you've clearly failed to see are the difficulties associated with your so-called safe supply, an approach that is actually harming people.
The question is, when will you read this study and when will you take actual science and the criticisms of this paper into account when you're making your policies?